Biomedical subjects
D D'Auria
Publications and source records attributed to D D'Auria.
Cost benefit vs. cost effectiveness--a new game plan for a new millennium?
Explore the source record for details and available documents.
Research--the basis of a new alliance?
Explore the source record for details and available documents.
Six characters in search of an author.
Explore the source record for details and available documents.
A collective responsibility.
Explore the source record for details and available documents.
Reality checks, CME and the pursuit of professionalism.
Explore the source record for details and available documents.
What is this life...?
Explore the source record for details and available documents.
Occupational medicine.
Explore the source record for details and available documents.
Cat on a hot tin roof.
Explore the source record for details and available documents.
In the footsteps of the father.
Explore the source record for details and available documents.
Cocktails and absent friends?
Explore the source record for details and available documents.
Summer showers.
Explore the source record for details and available documents.
The legacy of the night before.
Explore the source record for details and available documents.
Drug-induced impaired performance.
The use of medication is becoming increasingly common in the workforce in an effort to minimise the time away from work. Little is written about the behavioural impact of drugs and rarely is it considered in risk assessments. Employees may equally suffer from the effects of illicit drugs, alcohol or even the residual effects of anaesthesia after day-case or minimally invasive surgery. This paper sets out to accomplish three objectives: first, to review methods of evaluating behavioural effects of drugs, their strengths and weaknesses; second, to review established performance effects of principal classes of behaviourally toxic drugs on driving as a model; and third, to propose some guidelines to assist occupational physicians and other clinicians in assessing the risks incurred from drug-induced impaired performance.